These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23552405)

  • 21. Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia.
    Grollman AP; Jelaković B
    J Am Soc Nephrol; 2007 Nov; 18(11):2817-23. PubMed ID: 17942951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
    Hollstein M; Moriya M; Grollman AP; Olivier M
    Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aristolochic acid nephropathy: variation in presentation and prognosis.
    Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
    Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aristolochic acid nephropathy: A scientometric analysis of literature published from 1971 to 2019.
    Ji H; Hu J; Zhang G; Song J; Zhou X; Guo D
    Medicine (Baltimore); 2021 Jul; 100(27):e26510. PubMed ID: 34232183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aristolochic acid and its effect on different cancers in uro-oncology.
    Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T
    Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fifty years of Balkan endemic nephropathy in Romania: some aspects of the endemic focus in the Mehedinti county.
    Gluhovschi G; Margineanu F; Velciov S; Gluhovschi C; Bob F; Petrica L; Bozdog G; Trandafirescu V; Modalca M
    Clin Nephrol; 2011 Jan; 75(1):34-48. PubMed ID: 21176749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
    Grollman AP; Shibutani S; Moriya M; Miller F; Wu L; Moll U; Suzuki N; Fernandes A; Rosenquist T; Medverec Z; Jakovina K; Brdar B; Slade N; Turesky RJ; Goodenough AK; Rieger R; Vukelić M; Jelaković B
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12129-34. PubMed ID: 17620607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic remedies based on Aristolochia clematitis in the main foci of Balkan endemic nephropathy in Romania.
    Gluhovschi G; Margineanu F; Kaycsa A; Velciov S; Gluhovschi C; Bob F; Petrica L; Bozdog G; Dumitru S; Olosz E; Modalca M
    Nephron Clin Pract; 2010; 116(1):c36-46. PubMed ID: 20484934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.
    Slade N; Moll UM; Brdar B; Zorić A; Jelaković B
    Mutat Res; 2009 Apr; 663(1-2):1-6. PubMed ID: 19428366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.
    Arlt VM; Stiborová M; vom Brocke J; Simões ML; Lord GM; Nortier JL; Hollstein M; Phillips DH; Schmeiser HH
    Carcinogenesis; 2007 Nov; 28(11):2253-61. PubMed ID: 17434925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Diet on Aristolochic Acid-DNA Adduct Formation: Implications for Balkan Endemic Nephropathy Etiology.
    Zhang J; Chan CK; Pavlović NM; Chan W
    Chem Res Toxicol; 2023 Mar; 36(3):438-445. PubMed ID: 36881864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid.
    Stiborová M; Frei E; Schmeiser HH
    Kidney Int; 2008 Jun; 73(11):1209-11. PubMed ID: 18480852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy.
    Stiborová M; Frei E; Arlt VM; Schmeiser HH
    Mutat Res; 2008; 658(1-2):55-67. PubMed ID: 17851120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of the toxicity of aristolochic acid.
    Zhang HM; Zhao XH; Sun ZH; Li GC; Liu GC; Sun LR; Hou JQ; Zhou W
    J Clin Pharm Ther; 2019 Apr; 44(2):157-162. PubMed ID: 30548302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.
    Stiborová M; Arlt VM; Schmeiser HH
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and pathological spectrums of aristolochic acid nephropathy.
    Chen D; Tang Z; Luo C; Chen H; Liu Z
    Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in presentation and presence of DNA adducts and p53 mutations in patients with endemic nephropathy--an environmental form of the aristolochic acid nephropathy.
    Karanović S; Lela IV; Jelaković B; Dickman KG; Peić AK; Dittrich D; Knežević M; Matijević V; Fernandes AS; Miller F
    Kidney Blood Press Res; 2013; 37(1):1-8. PubMed ID: 23445829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and Removal of Aristolochic Acid in Natural Plants, Pharmaceuticals, and Environmental and Biological Samples: A Review.
    Wang C; Liu Y; Han J; Li W; Sun J; Wang Y
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.